Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series

Three patients diagnosed with severe COVID‐19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived. The thrid patient was diagnosed late and received...

Full description

Saved in:
Bibliographic Details
Published in:Clin Case Rep
Main Authors: Surabotsophon, Manoon, Klai‐On, Yingyot, Thanachartwet, Vipa, Khunapornphairote, Sirote, Chamnanchanunt, Supat, Racharak, Theerapat, Laisuan, Wannada, Sahassananda, Duangjai, Hapunna, Samlee, Jinapuk, Somjit, Leelasetakul, Suthee, Desakorn, Varunee
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Case Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675634/
https://ncbi.nlm.nih.gov/pubmed/33230415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3407
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items